Check out the new Prime/MRx GLP-1 Strategy page

March 14, 2024

After the release of its industry-leading research on GLP-1a drugs for weight loss in July 2023, Prime Therapeutics/Magellan Rx Management (Prime/MRx) continues to shape the narrative on this dynamic trend.

We’ve compiled all of our GLP-1 resources and thought leadership onto a new GLP-1 Strategy page, including our research, podcasts, videos, recent articles and more. Our aim is to highlight our evidence-based approach to GLP-1 drugs, working with our partners to develop individualized strategies that promote clinically appropriate use and consider total cost of care, long-term value, and member health outcomes.

For more, check back for regular updates on our Prime News site.

And to get the latest news and insights from Prime/MRx, sign-up for our twice-a-month newsletter, Prime Post.

Related news


July 16, 2024

LISTEN NOW: Beyond the business – Stories of corporate kindness | Pharmacy Friends Podcast

In this episode, we talk about how our employees' help goes beyond our work in health care, aiding in philanthropic efforts


July 12, 2024

August 2024 decisions expected from the FDA

Your monthly synopsis of new drugs expected to hit the market


July 12, 2024

High-Cost Therapy Profile: July 2024

Detailed information about Afamitresgene autoleucel Intravenous (IV)